论文部分内容阅读
将我院收治的120例1,2级高血压患者,随机分为对照组与治疗组,每组60例。对照组只给予苯磺酸左旋氨氯地平,治疗组同时给予苯磺酸左旋氨氯地平与替米沙坦治疗。结果治疗8周后,治疗组较对照组降压效果明显,治疗患者效率高,差异有统计学意义,且不良反应发生率低。结论苯磺酸左旋氨氯地平联合替米沙坦治疗1,2级(轻中度)高血压病比单用苯磺酸左旋氨氯地平降压效果好且不良反应发生率少。
120 cases of grade 1 and 2 hypertension treated in our hospital were randomly divided into control group and treatment group, 60 cases in each group. The control group was given only levamlodipine besylate, while the treatment group was treated with levamlodipine besylate and telmisartan. Results After 8 weeks of treatment, the antihypertensive efficacy of the treatment group was significantly higher than that of the control group. The treatment efficiency was high, the difference was statistically significant, and the incidence of adverse reactions was low. Conclusions L-amlodipine besylate combined with telmisartan is effective in lowering blood pressure of grade 1 and 2 (mild to moderate) than levamlodipine besylate alone and with a low incidence of adverse reactions.